4th Circ. Says OK To Zetia Class Certification Challenge
By Nadia Dreid ( November 3, 2020, 7:12 PM EST) -- The Fourth Circuit is going to hear a challenge mounted by pharmaceutical giants Merck and Glenmark to the certification of what they have called an "extremely small" class of drug buyers alleging the duo conspired to keep a generic version of the cholesterol drug Zetia off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.